DUBLIN, April 14, 2020 /PRNewswire/ -- The "Preclinical CRO Market Size, Share & Trends Analysis Report by Services (Bioanalysis & DMPK Studies, Toxicology Testing), by End Use (Biopharmaceutical Companies, Medical Device Companies), and Segment Forecasts, 2020-2027" report has been added to ResearchAndMarkets.com's offering.
The global preclinical CRO market size is expected to reach USD 7.8 billion by 2027, registering a CAGR of 8.3% over the forecast period.
The market is expected to show lucrative growth due to increasing R&D expenditure and rising outsourcing trend, which is expected to increase the demand for preclinical trials in the future. Whereas rise in number of complex drugs entering clinical trials and increasing R&D expenses are some of the factors responsible for the preclinical Contract Research Organization (CRO) growth. Increasing prices and changes in reimbursement policies are also anticipated to boost the in emerging countries such as India and China.
Increasing number of new entrants in market is anticipated to help the market to grow during the forecast period. Various companies are focusing on research and development of new drugs and therefore are outsourcing these activities to launch efficient CRO services in the market.
Further key findings from the report suggest:
- Toxicology testing held the largest share in the service segment in 2019 due to increasing trend of outsourcing, especially in emerging countries
- Bioanalysis is expected to grow with the highest CAGR of 8.8% over the forecast period
- North America dominates the market with the largest share of 47.5% in 2019 owing to advanced healthcare infrastructure in the region
- The Asia Pacific region is projected to witness the fastest growth during the forecast period owing to government support in development of outsourcing hubs along with availability of skilled practitioners
- Some of the key preclinical CRO market players are Envigo Corporation, MPI research, and Eurofins Scientific
Key Topics Covered
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Preclinical CRO Market Variables, Trends & Scope
Chapter 4. Preclinical CRO Market : Segment Analysis, by Services, 2016 - 2027 (USD Million)
4.1. Definitions & Scope
4.2. Product market share analysis, 2019 & 2027
4.3. Segment Dashboard
4.4. Global Preclinical CRO Market, by services, 2016 to 2027
4.5. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following:
4.5.1. Bioanalysis and DMPK studies
4.5.2. Toxicology testing
Chapter 5. Preclinical CRO Market : Segment Analysis, By End-use, 2016 - 2027 (USD Million)
5.1. Definitions & Scope
5.2. End-use market share analysis, 2019 & 2027
5.3. Segment Dashboard
5.4. Global Preclinical CRO market, by end-use, 2016 to 2027
5.5. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following:
5.5.1. Biopharmaceutical companies
5.5.2. Government and academic institutes
5.5.3. Medical device companies
Chapter 6. Preclinical CRO Market : Regional Market Analysis, By Services, 2016 - 2027 (USD Million)
Chapter 7. Preclinical CRO Market - Competitive Analysis
- Envigo Corporation
- MPI research
- Eurofins Scientific
- PRA Health Sciences, Inc.
- Wuxi AppTec
- Medpace, Inc.
- Pharmaceutical Product Development (PPD), LLC
- PARAXEL International Corporation
- ICON PLC
- Laboratory Corporation of America, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/61guet
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets